Cancer Pain Management in Patients Receiving Inpatient Specialized Palliative Care Services
Copyright © 2023 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved..
CONTEXT: Cancer pain is a common complication that is frequently undertreated in patients with cancer.
OBJECTIVES: This study is aimed at assessing the time needed to achieve cancer pain management goals through specialized palliative care (SPC).
METHODS: This was a multicenter, prospective, longitudinal study of inpatients with cancer pain who received SPC. Patients were continuously followed up until they considered cancer pain management successful, and we estimated this duration using the Kaplan-Meier method. We investigated the effectiveness of pain management using multiple patient-reported outcomes (PROs) and quantitative measures, including pain intensity change in the Brief Pain Inventory. A paired-sample t-test was used to compare the pain intensity at the beginning and end of the observation period.
RESULTS: Cancer pain management based on the PROs was achieved in 87.9% (385/438) of all cases. In 94.5% (364/385) of these cases, cancer pain management was achieved within 1 week, and the median time to pain management was 3 days (95% confidence interval [CI], 2-3). The mean worst pain intensity in the last 24 h at the start and end of observation were 6.9 ± 2.2 and 4.0 ± 2.3, respectively, with a difference of -2.9 (95% CI, -3.2 to -2.6; p < 0.01). Overall, 81.6% of the patients reported satisfaction with cancer pain management, and 62 adverse events occurred.
CONCLUSION: SPC achieved cancer pain management over a short period with a high level of patient satisfaction resulting in significant pain reduction and few documented adverse events.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:67 |
|---|---|
| Enthalten in: |
Journal of pain and symptom management - 67(2024), 1 vom: 09. Jan., Seite 27-38.e1 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tagami, Keita [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Analgesics |
|---|
| Anmerkungen: |
Date Completed 15.01.2024 Date Revised 15.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jpainsymman.2023.09.015 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362268401 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362268401 | ||
| 003 | DE-627 | ||
| 005 | 20240115231851.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jpainsymman.2023.09.015 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1260.xml |
| 035 | |a (DE-627)NLM362268401 | ||
| 035 | |a (NLM)37730073 | ||
| 035 | |a (PII)S0885-3924(23)00684-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tagami, Keita |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cancer Pain Management in Patients Receiving Inpatient Specialized Palliative Care Services |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.01.2024 | ||
| 500 | |a Date Revised 15.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a CONTEXT: Cancer pain is a common complication that is frequently undertreated in patients with cancer | ||
| 520 | |a OBJECTIVES: This study is aimed at assessing the time needed to achieve cancer pain management goals through specialized palliative care (SPC) | ||
| 520 | |a METHODS: This was a multicenter, prospective, longitudinal study of inpatients with cancer pain who received SPC. Patients were continuously followed up until they considered cancer pain management successful, and we estimated this duration using the Kaplan-Meier method. We investigated the effectiveness of pain management using multiple patient-reported outcomes (PROs) and quantitative measures, including pain intensity change in the Brief Pain Inventory. A paired-sample t-test was used to compare the pain intensity at the beginning and end of the observation period | ||
| 520 | |a RESULTS: Cancer pain management based on the PROs was achieved in 87.9% (385/438) of all cases. In 94.5% (364/385) of these cases, cancer pain management was achieved within 1 week, and the median time to pain management was 3 days (95% confidence interval [CI], 2-3). The mean worst pain intensity in the last 24 h at the start and end of observation were 6.9 ± 2.2 and 4.0 ± 2.3, respectively, with a difference of -2.9 (95% CI, -3.2 to -2.6; p < 0.01). Overall, 81.6% of the patients reported satisfaction with cancer pain management, and 62 adverse events occurred | ||
| 520 | |a CONCLUSION: SPC achieved cancer pain management over a short period with a high level of patient satisfaction resulting in significant pain reduction and few documented adverse events | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Analgesics | |
| 650 | 4 | |a cancer pain | |
| 650 | 4 | |a pain management | |
| 650 | 4 | |a palliative care | |
| 650 | 4 | |a palliative medicine | |
| 700 | 1 | |a Chiu, Shih-Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Kosugi, Kazuhiro |e verfasserin |4 aut | |
| 700 | 1 | |a Ishiki, Hiroto |e verfasserin |4 aut | |
| 700 | 1 | |a Hiratsuka, Yusuke |e verfasserin |4 aut | |
| 700 | 1 | |a Shimizu, Masaki |e verfasserin |4 aut | |
| 700 | 1 | |a Mori, Masanori |e verfasserin |4 aut | |
| 700 | 1 | |a Kubo, Emi |e verfasserin |4 aut | |
| 700 | 1 | |a Ikari, Tomoo |e verfasserin |4 aut | |
| 700 | 1 | |a Arakawa, Sayaka |e verfasserin |4 aut | |
| 700 | 1 | |a Eto, Tetsuya |e verfasserin |4 aut | |
| 700 | 1 | |a Shimoda, Mayu |e verfasserin |4 aut | |
| 700 | 1 | |a Hirayama, Hideyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Nishijima, Kaoru |e verfasserin |4 aut | |
| 700 | 1 | |a Ouchi, Kota |e verfasserin |4 aut | |
| 700 | 1 | |a Shimoi, Tatsunori |e verfasserin |4 aut | |
| 700 | 1 | |a Shigeno, Tomoko |e verfasserin |4 aut | |
| 700 | 1 | |a Yamaguchi, Takuhiro |e verfasserin |4 aut | |
| 700 | 1 | |a Miyashita, Mitsunori |e verfasserin |4 aut | |
| 700 | 1 | |a Morita, Tatsuya |e verfasserin |4 aut | |
| 700 | 1 | |a Inoue, Akira |e verfasserin |4 aut | |
| 700 | 1 | |a Satomi, Eriko |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of pain and symptom management |d 1991 |g 67(2024), 1 vom: 09. Jan., Seite 27-38.e1 |w (DE-627)NLM012642509 |x 1873-6513 |7 nnns |
| 773 | 1 | 8 | |g volume:67 |g year:2024 |g number:1 |g day:09 |g month:01 |g pages:27-38.e1 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jpainsymman.2023.09.015 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 67 |j 2024 |e 1 |b 09 |c 01 |h 27-38.e1 | ||